RT @Prison_Health: Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting…
Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs https://t.co/OH0u3LBsRf https://t.co/HUyy4wcMS8
Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs https://t.co/OH0u3LjRsF https://t.co/QiP68gv2n9
New on https://t.co/8pxKdRV8sp | Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs | https://t.co/Cy41BvlgTB https://t.co